Thursday, June 20, 2013 Last update: 5:08 AM
Company Tech News as it Breaks
VG Life Sciences Inc.
News articles for VG Life Sciences Inc.:
Thursday, January 31, 2013
- VG Life Sciences Reports Positive Results from First Stage of Ovarian Cancer Clinical Trial Using Sorafenib (Nexavar) Combined with HydroxychloroquineVG Life Sciences (OTC Pink: VGLS) reports details of the successful completion of the first stage of its Phase I Trial to treat ovarian cancer. The study ... read more
Monday, January 14, 2013
- VG Life Sciences Expands Ovarian Cancer Trial; Approved to Study Treatment of Breast, Colon, Lung, Liver and Pancreas CancerVG Life Sciences (OTC Pink: VGLS), has received approval from the Institutional Review Board of the University of Texas Health Science Center San Antonio to expand the types ... read more